𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hereditary nonpolyposis colorectal cancer: Frequent occurrence of large genomic deletions in MSH2 and MLH1 genes

✍ Scribed by Yaping Wang; Waltraut Friedl; Christof Lamberti; Matthias Jungck; Micaela Mathiak; Constanze Pagenstecher; Peter Propping; Elisabeth Mangold


Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
190 KB
Volume
103
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is often caused by a deficiency in DNA mismatch repair. By using conventional methods of mutation analysis, point mutations in the DNA mismatch repair genes MSH2 and MLH1 have been detected in up to 64% of patients suspected of HNPCC. However, large genomic deletions cannot be detected by these methods. In our study, we applied a semiquantitative multiplex PCR to detect the proportion of large deletions in patients meeting the Bethesda criteria whose tumours exhibited microsatellite instability (MSI). Of 368 unrelated patients, 180 exhibited MSI. In these patients, 68 disease‐causing point mutations (38%) had previously been detected in the MSH2 and MLH1 genes by SSCP, heteroduplex analysis or DHPLC followed by direct sequencing. The remaining 112 patients (including 24 patients with rare missense or other unclarified variants) were examined for large deletions. We identified deletions in 19 patients (10.6%); 11/19 (58%) deletions were located in MSH2 and 8/19 (42%) in MLH1, respectively. The size of deletions ranged from 1 exon to a deletion of a whole gene. Five breakpoints of deletions were sequenced; Alu‐repetitive elements were involved in all of them. In patients meeting the Amsterdam criteria the proportion of large deletions was 12.6%. A similar proportion of deletions was found in the group of patients with a positive family history for colorectal cancer and MSI tumours, not meeting the Amsterdam criteria. The results of our study suggest that large genomic deletions in both MSH2 and MLH1 genes play a considerable role in the pathogenesis of HNPCC and should be part of the routine HNPCC mutation detection protocols. Β© 2002 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Four novel MSH2 and MLH1 frameshift muta
✍ Oana Caluseriu; Emanuela Lucci Cordisco; Alessandra Viel; Silvia Majore; Riccard πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 2 views

Ministero dell'UniversitΓ  e della Ricerca Scientifica (MURST) COFIN99; Ministero della SanitΓ  (Progetti Finalizzati) Communicated by Mark H. Paalman Hereditary nonpolyposis colorectal cancer (HNPCC) is caused by mutations of genes encoding for proteins of the mismatch repair (MMR) machinery. The maj

Characterization of MSH2 and MLH1 mutati
✍ Alessandra Viel; Maurizio Genuardi; Eugenia Capozzi; Francesca Leonardi; Alfonso πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 331 KB πŸ‘ 2 views

Mismatch repair genes MSH2 and MLH1 are considered to be the two major genes that are responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Germline heterozygous inactivating mutations of MSH2 and MLH1 have been identified previously in a substantial fraction of individuals who are pred

Genomic deletions in MSH2 or MLH1 are a
✍ C.F. Taylor; R.S. Charlton; J. Burn; E. Sheridan; G.R. Taylor πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 179 KB πŸ‘ 2 views

Gene dosage abnormalities account for a significant proportion of the mutations in genes tested in DNA diagnostic laboratories. Detection of these changes has proved a challenge as the methods available to date are time consuming or unreliable. The multiplex ligation-dependent probe assay (MLPA) is

MLH1 and MSH2 constitutinal mutations in
✍ Maurizio Genuardi; Marcello Anti; Eugenia Capozzi; Francesca Leonardi; Mara Forn πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 67 KB πŸ‘ 2 views

## Genetic diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC ) may have a significant impact on the clinical management of patients and their at-risk relatives. At present, clinical criteria represent the simplest and most useful method for the identification of HNPCC families and for

Spectrum and frequencies of mutations in
✍ Elisabeth Mangold; Constanze Pagenstecher; Waltraut Friedl; Micaela Mathiak; Rei πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 126 KB

Mutations in DNA MMR genes, mainly MSH2 and MLH1, account for the majority of HNPCC, an autosomal dominant predisposition to colorectal cancer and other malignancies. The evaluation of many questions regarding HNPCC requires clinically and genetically well-characterized HNPCC patient cohorts of reas